Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Perioperative data

From: Concomitant ablation of atrial fibrillation in octogenarians: an observational study

   Age < 80 yrs (n = 172) Age ≥ 80 yrs (n = 28) p
betablocker % (n) 27.9 (48) 17.8 (5) 0.172
class III antiarrhythmic drugs % (n) 52.3 (90) 60.7 (17) 0.409
   Sotalol % (n) 76.7 (69) 58.8 (10) 0.125
   Amiodaron % (n) 23.3 (21) 41.2 (7) 0.125
DC shock cardioversion % (n) 4.6 (8) 3.6 (1) 0.798
pacemaker implantation % (n) 3.5 (6) - -
re-exploration for bleeding % (n) 2.3 (4) - -
pericardial effusion % (n) 1.2 (2) - -
heart failure % (n) 4.1 (7) 7.1 (2) 0.467
   inotropic support % (n) 4.1 (7) 7.1 (2) 0.467
   IABP % (n) 2.9 (5) 5.1 (4) 0.045
   LVAD % (n) 1.2 (2) - -
pulmonary failure % (n) - 3.6 (1) -
renal failure % (n) 7.0 (12) 17.8 (5) 0.056
cerebrovascular accident % (n) 1.7 (3) 3.6 (1) 0.522
intracerebral hemorrhage % (n) 0.6 (1) - -
infection % (n) 4.6 (8) 10.7 (3) 0.192
   mediastinitis % (n) 0.6 (1) 3.6 (1) 0.140
   bronchopulmonary infection % (n) 4.1 (7) 7.1 (2) 0.467
   sepsis % (n) 2.3 (4) 10.7 (3) 0.025
mechanical ventilation time hrs 21 ± 50.3 28 ± 41.1 0.069
ICU stay days 4 ± 7.2 8 ± 16.9 0.027
hospital stay days 14 ± 30.8 20 ± 23.9 0.004
mortality (30 days) % (n) 4.6 (8) 14.3 (4) 0.046
cardiac death % (n) 0.6 (1) 3.6 (1) 0.140
non-cardiac death % (n) 4.1 (7) 10.7 (3) 0.135
  1. DC, direct current; IABP, intraaortic balloon pump; ICU, intensive care unit; LVAD, left ventricular assist device; yrs, years